Kang and colleagues studied serum PTH in 115 patients with multiple myeloma (a malignancy arising in the bone marrow from abnormal plasma cells) and found inferior progression-free survival in the group with high PTH levels compared to the group with normal PTH levels. Here, PTH is linked to AL amyloidosis.